GLP-1s emerge as one of most ‘disruptive economic forces’ in healthcare
A panel examines the expansion of GLP-1 medications beyond weight loss, exploring new medical uses, potential side effects and what the next wave of these blockbuster drugs could mean for patients on ‘Barron’s Roundtable.’ A new report by Wells Fargo spotlights how GLP-1 weight loss drugs are reshaping the healthcare industry by addressing obesity. Wells … Read more